Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi at her Raleigh, N.C., office on Tuesday, Aug. 15, 2015. After two rejections, the U.S. Food and Drug Administration gave approval Tuesday for the drug, also known as flibanserin, as a treatment for hypoactive sexual desire disorder, a first for women. (AP Photo/Allen G. Breed)

Comments are not available on this story.

Augusta and Waterville news

Get news and events from your towns in your inbox every Friday.
  • This field is for validation purposes and should be left unchanged.